ALMA LUJAN: Open Payments
NPI 1215673025 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 30 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $416 · 2025 $755
Food & beverage: $577Education: $178
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| SEAGEN INC. | 1 | $100 |
| Celgene Corporation | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Lilly USA, LLC | 2 | $36 |
| ABBVIE INC. | 1 | $34 |
| Gilead Sciences, Inc. | 1 | $29 |
| Aveo Pharmaceuticals, Inc. | 1 | $22 |
| Geron Corporation | 1 | $22 |
Products named: REBLOZYL, PLUVICTO, KISQALI, VERZENIO, IMBRUVICA, OJJAARA, Trodelvy, JAKAFI.
Industry payments across NM — which companies pay providers there.
